eMedicine Specialties > Plastic Surgery > Skin

Vascular, Capillary Malformations

Author: Ashok Tholpady, MS, University of Virginia School of Medicine
Coauthor(s): Thomas J Gampper, MD, Vice Chair, Department of Surgery, Director of Aesthetic and Laser Surgery, Associate Professor, Departments of Plastic Surgery and Clinical Neurosurgery, University of Virginia
Contributor Information and Disclosures

Updated: Jan 27, 2009

Introduction

History of the Procedure

Vascular malformations have been recognized throughout history as birthmarks. The cause was thought to be maternal cravings for fruit or maternal dreams, moods, and fantasies. Although Blondel disproved these theories in 1727, some persist today. In 1866, Dugas conducted a scientific analysis of birthmarks and concluded that they were caused by defects in embryologic development. Later, Dupuytren classified vascular malformations as erectile tumors. Virchow and Wagner established the first classification system of vascular malformations, based on channel architecture and histomorphologic appearance.

Problem

Vascular malformations have been categorized using confusing, inaccurate, and inconsistent terminology. A significant number of patients with vascular lesions receive ineffective and potentially harmful treatment based on misclassification. Mulliken classified vascular malformations using understandable and accurate nomenclature. Vascular malformations are subdivided into low-flow (capillary, venous, lymphatic, or a combination thereof) and high-flow (arterial) anomalies. Clinical, histological, histochemical, and biochemical differences and radiographic imaging findings support this classification.

Frequency

The prevalence at birth of capillary malformations is reported at 0.3% without predisposition to either sex.

Etiology

Capillary malformations were once referred to as port-wine stains; this term is now outdated. Genetic studies have mapped capillary malformations to chromosome 5q14-21, showing a defect in the RASA1 gene. The RASA1 gene encodes p120 Ras GTPase-activating protein. When mutated, p120 Ras GTPase-activating protein binds to Krev-1/rap1a, an integrin β1–mediated cell adhesion and angiogenesis protein. The pathogenesis of capillary malformations is not understood.

Pathophysiology

Capillary malformations are the most common cutaneous vascular malformation appearing as a macular stain. Capillary malformations are represented by ectatic capillaries and medium-sized venules with thin walls and flat endothelial cells. The lack of sympathetic innervation regulating blood flow in vessels with capillary malformation is believed to produce progressive ectasia. Consequently, a characteristic red and purple lesion is seen upon examination.

Unlike hemangiomas, capillary malformations do not undergo spontaneous involution. Further, the endothelium does not exhibit hyper-proliferation but has a normal turnover rate. In a study of 415 patients with capillary malformations in the fifth decade of life, Geronemus and Ashinoff found hypertrophy, nodules, or both in 65% of the capillary vasculature.1 In addition to these features, bridged fenestrations can be seen by scanning electron microscopy. These are normally found in venous capillaries surrounding sweat glands and hair follicles and represent areas of accelerated exchange between circulation and surrounding tissue.

Controversy remains as to whether the thickening of postcapillary venules from basement membrane deposition actually occurs.

Presentation

Patient history and physical examination findings are important in order to correctly classify these malformations. Appropriate treatment begins with the correct diagnosis.

The general consensus is that capillary malformations are located in the dermis. They present as well-defined patches of red or purple skin discoloration at birth but may be masked by erythema of neonatal skin. Their growth correlates closely with the person’s age, becoming increasingly nodular and covering larger areas with time.

Although capillary malformations can occur anywhere on the body, they are most commonly seen on the face. When capillary malformations occur on the face, they normally have a dermatomal distribution. Fifty-five percent of facial capillary malformations overlap sensory dermatomes, occur bilaterally, or cross the mid line. The remaining 45% occur in one of the three trigeminal dermatomes. Maxillary or mandibular overgrowth with labial hypertrophy and gingival hyperplasia may be seen in the lower and mid face. Soft tissue and skeletal overgrowth may also be seen in cutaneous capillary malformations of the trunk and limbs.

Capillary malformations are commonly associated with developmental defects. For example, a capillary malformation on the posterior chest may be indicative of an underlying arteriovenous malformation (AVM) of the spinal cord (Cobb syndrome), or an occipital capillary malformation may overlie an encephalocele. Spinal dysraphism, lipomeningocele, tethered spinal cord, and diastematomyelia may be present when the capillary malformation overlies the cervical or lumbosacral spine. In these cases, careful neurologic examination, radiographic examination, spinal radiographic imaging, and bladder function studies are indicated because subtle signs of neurogenic bladder dysfunction or lower extremity weakness may be present.

Syndromes Involving Capillary Malformations

Klippel-Trenaunay-Weber syndrome

Klippel-Trenaunay-Weber syndrome is often associated with the triad of capillary malformations, venous malformations or varicose veins, and hypertrophy of affected tissues. Vascular abnormalities lead to muscle hypertrophy and thickening of the skin, subcutaneous tissues, and bone. Although port-wine stains commonly occur cutaneously, venous and lymphatic malformations are common in the limbs. Most often, they affect a single lower extremity. A persistent lateral vein extending from the lateral malleolus to the gluteal region is common.

Parkes Weber syndrome

Parkes Weber syndrome is the combination of a capillary malformation and an AVM. It is commonly large and pink, with the affected limb being longer and warmer than the contralateral limb.

Hyperkeratotic cutaneous capillary-venous malformation

The hyperkeratotic cutaneous capillary-venous malformation is normally associated with vascular malformation of the brain and affects the tissue around the eye. It is an autosomal dominant abnormality due to a mutation in the KRIT1 gene.

Sturge-Weber syndrome

Sturge-Weber syndrome is a capillary malformation in the distribution of the ophthalmic and maxillary divisions of the trigeminal nerve of the face. This vascular malformation may be associated with many other symptoms, such as jacksonian seizures, mental retardation, calcification of the leptomeninges, glaucoma, and contralateral hemiplegia.

Relevant Anatomy

Unlike hemangiomas, capillary malformations display ectatic vessels with flat nonproliferative endothelium. Thickening of the postcapillary venule wall is a common finding. In addition, bridged fenestrations can be seen by electron microscopy.

More on Vascular, Capillary Malformations

Overview: Vascular, Capillary Malformations
Workup: Vascular, Capillary Malformations
Treatment: Vascular, Capillary Malformations
Follow-up: Vascular, Capillary Malformations
Multimedia: Vascular, Capillary Malformations
References
[ CLOSE WINDOW ]

References

  1. Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. Jan 1991;17(1):76-9. [Medline].

  2. Arneja JS, Gosain AK. Vascular malformations. Plast Reconstr Surg. Apr 2008;121(4):195e-206e. [Medline].

  3. Katugampola GA, Lanigan SW. Five years' experience of treating port wine stains with the flashlamp-pumped pulsed dye laser. Br J Dermatol. Nov 1997;137(5):750-4. [Medline].

  4. Tan OT, Sherwood K, Gilchrest BA. Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med. Feb 16 1989;320(7):416-21. [Medline].

  5. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther. Apr 2003;5(1):7-13. [Medline].

  6. Kono T, Groff WF, Sakurai H. Treatment of port wine stains with the pulse dye laser. Ann Plast Surg. Apr 2006;56(4):460-3. [Medline].

  7. McGill DJ, Mackay IR. Capillary vascular malformation response to increased ambient temperature is dependent upon anatomical location. Ann Plast Surg. Feb 2007;58(2):193-9. [Medline].

  8. Raulin C, Greve B, Hammes S. Cold air in laser therapy: first experiences with a new cooling system. Lasers Surg Med. 2000;27(5):404-10. [Medline].

  9. Greve B, Hammes S, Raulin C. The effect of cold air cooling on 585 nm pulsed dye laser treatment of port-wine stains. Dermatol Surg. Jul 2001;27(7):633-6. [Medline].

  10. Nelson JS, Kimel S. Safety of cryogen spray cooling during pulsed laser treatment of selected dermatoses. Lasers Surg Med. 2000;26(1):2-3. [Medline].

  11. Chang CJ, Nelson JS. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage. Dermatol Surg. Oct 1999;25(10):767-72. [Medline].

  12. Chess C. Does simultaneous contact cooling reduce intravascular temperature during laser irradiation and impinge on selective vascular destruction?. Dermatol Surg. Mar 1998;24(3):404-5. [Medline].

  13. Waldorf HA, Alster TS, McMillan K, Kauvar AN, Geronemus RG, Nelson JS. Effect of dynamic cooling on 585-nm pulsed dye laser treatment of port-wine stain birthmarks. Dermatol Surg. Aug 1997;23(8):657-62. [Medline].

  14. Breugem CC, Hennekam RC, van Gemert MJ, van der Horst CM. Are capillary malformations neurovenular or purely neural?. Plast Reconstr Surg. Feb 2005;115(2):578-87. [Medline].

  15. Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther. May-Jun 2005;18(3):267-81. [Medline].

  16. Barsky SH, Rosen S, Geer DE, Noe JM. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol. Mar 1980;74(3):154-7. [Medline].

  17. Bauer BS, Kernahan DA, Hugo NE. Lymphangioma circumscriptum--a clinicopathological review. Ann Plast Surg. Oct 1981;7(4):318-26. [Medline].

  18. Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. Dec 2003;73(6):1240-9. [Medline].

  19. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol. Dec 1993;10(4):311-3. [Medline].

  20. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. Dec 1983;18(6):894-900. [Medline].

  21. Frech M, John J, Pizon V, Chardin P, Tavitian A, Clark R, et al. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science. Jul 13 1990;249(4965):169-71. [Medline].

  22. Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg. Aug 2002;110(2):572-85; quiz 586; discussion 587-8. [Medline].

  23. Goldman MP, Fitzpatrick RE, Ruiz-Esparza J. Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser. J Pediatr. Jan 1993;122(1):71-7. [Medline].

  24. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. Aug 1976;58(2):218-22. [Medline].

  25. Katugampola GA, Lanigan SW. Five years' experience of treating port wine stains with the flashlamp-pumped pulsed dye laser. Br J Dermatol. Nov 1997;137(5):750-4. [Medline].

  26. Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol. Aug 1998;139(2):173-7. [Medline].

  27. Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. Jan 2005;32(1):99-116, ix. [Medline].

  28. Mulliken JB. Cutaneous vascular anomalies. In: McCarthy JG, ed. Plastic Surgery. Philadelphia, Pa: WB Saunders; 1990:. 3191-274.

  29. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. Mar 1982;69(3):412-22. [Medline].

  30. Nelson JS, Applebaum J. Clinical management of port-wine stain in infants and young children using the flashlamp-pulsed dye laser. Clin Pediatr (Phila). Sep 1990;29(9):503-8; discussion 509. [Medline].

  31. Orten SS, Waner M, Flock S, Roberson PK, Kincannon J. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. Nov 1996;122(11):1174-9. [Medline].

  32. Rak KM, Yakes WF, Ray RL, Dreisbach JN, Parker SH, Luethke JM, et al. MR imaging of symptomatic peripheral vascular malformations. AJR Am J Roentgenol. Jul 1992;159(1):107-12. [Medline].

  33. Schneider BV, Mitsuhashi Y, Schnyder UW. Ultrastructural observations in port wine stains. Arch Dermatol Res. 1988;280(6):338-45. [Medline].

  34. Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels?. Arch Dermatol. Feb 1986;122(2):177-9. [Medline].

  35. Wang QK. Update on the molecular genetics of vascular anomalies. Lymphat Res Biol. 2005;3(4):226-33. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

capillary malformation, capillary malformations, telangiectatic  nevi, low-flow vascular malformation, birthmark, birth mark, hyperkeratotic cutaneous capillary-venous malformation, Parkes-Weber vascular lesion, capillary anomaly, low-flow vascular anomaly, Klippel-Trenaunay-Weber syndrome, Sturge-Weber syndrome, port-wine stain

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Ashok Tholpady, MS, University of Virginia School of Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Thomas J Gampper, MD, Vice Chair, Department of Surgery, Director of Aesthetic and Laser Surgery, Associate Professor, Departments of Plastic Surgery and Clinical Neurosurgery, University of Virginia
Thomas J Gampper, MD is a member of the following medical societies: American Association of Plastic Surgeons, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery, American Society of Plastic Surgeons, Association of Academic Chairmen of Plastic Surgery, and Undersea and Hyperbaric Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Shahin Javaheri, MD, Chief, Department of Plastic Surgery, Martinez Veterans Affairs Outpatient Clinic; Consulting Staff, Advanced Aesthetic Plastic & Reconstructive Surgery
Shahin Javaheri, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery and American Society of Plastic Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Wayne Stadelmann, MD, Stadelmann Plastic Surgery, PC
Wayne Stadelmann, MD is a member of the following medical societies: Alpha Omega Alpha, New Hampshire Medical Society, Northeastern Society of Plastic Surgeons, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Nicolas (Nick) G Slenkovich, MD, Director, Colorado Plastic Surgery Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.

Chief Editor

Jorge I de la Torre, MD, FACS, Professor of Surgery and Physical Medicine and Rehabilitation, Residency Program Director, Division of Plastic Surgery, University of Alabama at Birmingham; Director, Center for Advanced Surgical Aesthetics
Jorge I de la Torre, MD, FACS is a member of the following medical societies: American Association of Plastic Surgeons, American Burn Association, American College of Surgeons, American Medical Association, American Society for Laser Medicine and Surgery, American Society for Reconstructive Microsurgery, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Association for Academic Surgery, and Medical Association of the State of Alabama
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.